FindTrial
Sign In

Eye Problems in People with Blood Cancers

Ocular findings in Patients with Hematological Malignancies - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/113190
Enrollment
97
Registered
2026-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue Health Condition 2: H00-H59- Diseases of the eye and adnexa

Interventions

Intervention1: Nil: Nil Intervention2: NIL: NIL as it is an observational study

Sponsors

Medha Singhal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of hematological malignancy 2. Able to provide informed consent

Exclusion criteria

Exclusion criteria: 1. History of ocular surgery within the past 6 months. 2. Patients with neurological or mental incapacity rendering them unable to consent or cooperate with ophthalmic evaluation. 3. Critically ill patients for whom ocular examination is not feasible

Design outcomes

Primary

MeasureTime frame
Prevalence and pattern of ophthalmic manifestations in patients wth hematological malignanciesTimepoint: At baseline—

Secondary

MeasureTime frame
Associations between ocular manifesations & hematological parametersTimepoint: At baseline;Idenitification of independednt predictors via logistic regressionTimepoint: At baseline—

Countries

India

Contacts

Public ContactMedha Singhal

Kasturba Medical College

medhasinghal29@gmail.com9471129841

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026